Fe-salphen complexes from intracellular pH-triggered degradation ofFe3O4@Salphen-InIII CPPs for selectively killing cancer cells

Biomaterials

Volumn 35, Issue 5, 2014, Pages 1676-1685

  Xu, Shuai ^a   Liu, Jing ^b   Li, Dian ^a   Wang, Liming ^c   Guo, Jia ^a   Wang, Changchun ^a   Chen, Chunying ^b  

^a FUDAN UNIVERSITY   (China)

^b NATIONAL CENTER FOR NANOSCIENCE AND TECHNOLOGY   (China)

^c INSTITUTE OF HIGH ENERGY PHYSICS   (China)

Author keywords

Coordination polymer; Magnetic nanoparticle; Metal complex; Prodrug; Target drug delivery

Indexed keywords

ACTIVE COMPLEXES; CASPASE ACTIVATION; COLLOIDAL CLUSTERS; COMPOSITE NANOPARTICLES; COORDINATION POLYMERS; MAGNETIC NANO-PARTICLES; PRODRUGS; SYNTHETIC STRATEGIES;

CELLS; DRUG DELIVERY; METAL COMPLEXES; NANOMAGNETICS; NANOPARTICLES; POLYMERS;

IRON COMPOUNDS;

CASPASE; IRON OXIDE SALPHEN INDIUM COORDINATION POLYMER NANOPARTICLE; MAGNETIC NANOPARTICLE; METAL COMPLEX; PRODRUG; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER GROWTH; CANCER INHIBITION; CARCINOMA CELL; CELL PH; CELL PROLIFERATION; CONTROLLED STUDY; DEGRADATION; DRUG CYTOTOXICITY; DRUG DEGRADATION; DRUG SYNTHESIS; DRUG UPTAKE; ENZYME ACTIVATION; EPITHELIUM CELL; LYSOSOME; PHOTOLUMINESCENCE; PRIORITY JOURNAL;

COORDINATION POLYMER; MAGNETIC NANOPARTICLE; METAL COMPLEX; PRODRUG; TARGET DRUG DELIVERY;

BLOTTING, WESTERN; CELL LINE, TUMOR; FERRIC COMPOUNDS; HUMANS; HYDROGEN-ION CONCENTRATION; MAGNETITE NANOPARTICLES; MICROSCOPY, ELECTRON, TRANSMISSION; NEOPLASMS; PHENYLENEDIAMINES; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; THERMOGRAVIMETRY;

EID: 84890175367     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2013.10.081     Document Type: Article

References (59)

1. Hambley T.W. Metal-based therapeutics. Science 2007, 318:1392-1393.
2. Kang S.-G., Zhou G., Yang P., Liu Y., Sun B., Huynh T., et al. Molecular mechanism of pancreatic tumor metastasis inhibition by Gd@C82(OH)22 and its implication for de novo design of nanomedicine. Proc Natl Acad Sci U S A 2012, 109:15431-15436.
3. van Rijt S.H., Sadler P.J. Current applications and future potential for bioinorganic chemistry in the development of anticancer drugs. Drug Discov Today 2009, 14:1089-1097.
4. Wang L., Liu Y., Li W., Jiang X., Ji Y., Wu X., et al. Selective targeting of gold nanorods at the mitochondria of cancer cells: implications for cancer therapy. Nano Lett 2010, 11:772-780.
5. Zhang Z., Wang J., Chen C. Near-infrared light-mediated nanoplatforms for cancer thermo-chemotherapy and optical imaging. Adv Mater 2013, 25:3869-3880.
6. Li Y.F., Chen C. Fate and toxicity of metallic and metal-containing nanoparticles for biomedical applications. Small 2011, 7:2965-2980.
7. Zhang Z., Wang L., Wang J., Jiang X., Li X., Hu Z., et al. Mesoporous silica-coated gold nanorods as a light-mediated multifunctional theranostic platform for cancer treatment. Adv Mater 2012, 24:1418-1423.
8. Rosenberg B., Vancamp L. Platinum compounds: a new class of potent antitumour agents. Nature 1969, 222:385-386.
9. Fricker S.P. Metal based drugs: from serendipity to design. Dalton Trans 2007, 43:4903-4917.
10. Gasser G., Ott I., Metzler-Nolte N. Organometallic anticancer compounds. JMed Chem 2010, 54:3-25.
11. Zhang C.X., Lippard S.J. New metal complexes as potential therapeutics. Curr Opin Chem Biol 2003, 7:481-489.
12. Kelland L. The resurgence of platinum-based cancer chemotherapy. Nat Rev Cancer 2007, 7:573-584.
13. Dempke W., Voigt W., Grothey A., Hill B.T., Schmoll H.-J. Cisplatin resistance and oncogenes-a review. Anticancer Drugs 2000, 11:225-236.
14. Jung Y., Lippard S.J. Direct cellular responses to platinum-induced DNA damage. Chem Rev 2007, 107:1387-1407.
15. Johnstone T.C., Kulak N., Pridgen E.M., Farokhzad O.C., Langer R., Lippard S.J. Nanoparticle encapsulation of mitaplatin and the effect thereof on invivo properties. ACS Nano 2013, 7:5675-5683.
16. Gupta K., Sutar A.K. Catalytic activities of Schiff base transition metal complexes. Coord Chem Rev 2008, 252:1420-1450.
17. Ansari K.I., Grant J.D., Kasiri S., Woldemariam G., Shrestha B., Mandal S.S. Manganese (III)-salens induce tumor selective apoptosis in human cells. JInorg Biochem 2009, 103:818-826.
18. Ansari K.I., Grant J.D., Woldemariam G.A., Kasiri S., Mandal S.S. Iron (III)-salen complexes with less DNA cleavage activity exhibit more efficient apoptosis in MCF7 cells. Org Biomol Chem 2009, 7:926-932.
19. Ansari K.I., Kasiri S., Grant J.D., Mandal S.S. Fe(III)-salen and -salphen complexes induce caspase activation and apoptosis in human cells. JBiomol Screen 2011, 16:26-35.
20. Woldemariam G.A., Mandal S.S. Iron(III)-salen damages DNA and induces apoptosis in human cell via mitochondrial pathway. JInorg Biochem 2008, 102:740-747.
21. Ansari K., Kasiri S., Grant J.D., Mandal S.S. Apoptosis and anti-tumour activities of manganese(III)-salen and -salphen complexes. Dalton Trans 2009, 40:8525-8531.
22. Lainé A.-L., Passirani C. Novel metal-based anticancer drugs: a new challenge in drug delivery. Curr Opin Pharmacol 2012, 12:420-426.
23. Rodgers M., Armentrout P. Athermodynamic "vocabulary" for metal ion interactions in biological systems. Acc Chem Res 2004, 37:989-998.
24. Oh M., Mirkin C.A. Chemically tailorable colloidal particles from infinite coordination polymers. Nature 2005, 438:651-654.
25. Spokoyny A.M., Kim D., Sumrein A., Mirkin C.A. Infinite coordination polymer nano-and microparticle structures. Chem Soc Rev 2009, 38:1218-1227.
26. Farha O.K., Spokoyny A.M., Mulfort K.L., Galli S., Hupp J.T., Mirkin C.A. Gas-sorption properties of cobalt(II)-carborane-based coordination polymers as a function of morphology. Small 2009, 5:1727-1731.
27. Jeon Y.M., Armatas G.S., Heo J., Kanatzidis M.G., Mirkin C.A. Amorphous infinite coordination polymer microparticles: a new class of selective hydrogen storage materials. Adv Mater 2008, 20:2105-2110.
28. Lee H.J., Cho W., Jung S., Oh M. Morphology-selective formation and morphology-dependent gas-adsorption properties of coordination polymer particles. Adv Mater 2009, 21:674-677.
29. Huxford R.C., Boyle W.S., Liu D., Lin W. Lipid-coated nanoscale coordination polymers for targeted delivery of antifolates to cancer cells. Chem Sci 2012, 3:198-204.
30. Imaz I., Rubio-Martínez M., García-Fernández L., García F., Ruiz-Molina D., Hernando J., et al. Coordination polymer particles as potential drug delivery systems. Chem Commun 2010, 46:4737-4739.
31. Rieter W.J., Pott K.M., Taylor K.M., Lin W. Nanoscale coordination polymers for platinum-based anticancer drug delivery. JAm Chem Soc 2008, 130:11584-11585.
32. Xing L., Cao Y., Che S. Synthesis of core-shell coordination polymer nanoparticles (CPNs) for pH-responsive controlled drug release. Chem Commun 2012, 48:5995-5997.
33. Xing L., Zheng H., Cao Y., Che S. Coordination polymer coated mesoporous silica nanoparticles for pH-responsive drug release. Adv Mater 2012, 24:6433-6437.
34. Xing L., Zheng H., Che S. ApH-responsive cleavage route based on a metal-organic coordination bond. Chem Eur J 2011, 17:7271-7275.
35. Li H., Sun X. Fluorescence-enhanced nucleic acid detection: using coordination polymer colloids as a sensing platform. Chem Commun 2011, 47:2625-2627.
36. Aimé C., Nishiyabu R., Gondo R., Kimizuka N. Switching on luminescence in nucleotide/lanthanide coordination nanoparticles via synergistic interactions with a cofactor ligand. Chem Eur J 2010, 16:3604-3607.
37. Imaz I., Hernando J., Ruiz-Molina D., Maspoch D. Metal-organic spheres as functional systems for guest encapsulation. Angew Chem Int Ed 2009, 48:2325-2329.
38. Liu D., Huxford R.C., Lin W. Phosphorescent nanoscale coordination polymers as contrast agents for optical imaging. Angew Chem Int Ed 2011, 50:3696-3700.
39. Nishiyabu R., Aimé C., Gondo R., Kaneko K., Kimizuka N. Selective inclusion of anionic quantum dots in coordination network shells of nucleotides and lanthanide ions. Chem Commun 2010, 46:4333-4335.
40. Nishiyabu R., Hashimoto N., Cho T., Watanabe K., Yasunaga T., Endo A., et al. Nanoparticles of adaptive supramolecular networks self-assembled from nucleotides and lanthanide ions. JAm Chem Soc 2009, 131:2151-2158.
41. 4@coordination polymer microspheres with self-supported polyoxometalates in shells exhibiting high-performance supercapacitive energy storage. Chem Commun 2013, 49:2427-2429.
42. Choi J., Yang H.Y., Kim H.J., Son S.U. Organometallic hollow spheres bearing bis (N-heterocyclic carbene)-palladium species: catalytic application in three-component strecker reactions. Angew Chem Int Ed 2010, 49:7718-7722.
43. Park K.H., Jang K., Son S.U., Sweigart D.A. Self-supported organometallic rhodium quinonoid nanocatalysts for stereoselective polymerization of phenylacetylene. JAm Chem Soc 2006, 128:8740-8741.
44. Kitaura R., Onoyama G., Sakamoto H., Matsuda R., Si Noro, Kitagawa S. Immobilization of a metallo schiff base into a microporous coordination polymer. Angew Chem Int Ed 2004, 43:2684-2687.
45. Jo C., Lee H.J., Oh M. One-pot synthesis of silica@coordination polymer core-shell microspheres with controlled shell thickness. Adv Mater 2011, 23:1716-1719.
46. Liu J., Sun Z., Deng Y., Zou Y., Li C., Guo X., et al. Highly water-dispersible biocompatible magnetite particles with low cytotoxicity stabilized by citrate groups. Angew Chem Int Ed 2009, 48:5875-5879.
47. Graf N., Lippard S.J. Redox activation of metal-based prodrugs as a strategy for drug delivery. Adv Drug Deliv Rev 2012, 64:993-1004.
48. Luo B., Xu S., Luo A., Wang W.R., Wang S.L., Guo J., et al. Mesoporous biocompatible and acid-degradable magnetic colloidal nanocrystal clusters with sustainable stability and high hydrophobic drug loading capacity. ACS Nano 2011, 5:1428-1435.
49. Guo J., Yang W.L., Wang C.C. Magnetic colloidal supraparticles: design, fabrication and biomedical applications. Adv Mater 2013, 25:5196-5214.
50. 4 microspheres for magnetic-targeted and pH-triggered anticancer drug delivery. Chem Eur J 2012, 18:15676-15682.
51. Chikazumi S. Physics of ferromagnetism 1997, Oxford University Press, New York. 2nd ed.
52. Chen Z., Yin J.-J., Zhou Y.T., Zhang Y., Song L., Song M., et al. Dual enzyme-like activities of iron oxide nanoparticles and their implication for diminishing cytotoxicity. ACS Nano 2012, 6:4001-4012.
53. Li D., Tang J., Wei C., Guo J., Wang S., Chaudhary D., et al. Doxorubicin-conjugated mesoporous magnetic colloidal nanocrystal clusters stabilized by polysaccharide as a smart anticancer drug vehicle. Small 2012, 8:2690-2697.
54. 2+ detection. Chem Eur J 2010, 16:12898-12903.
55. Chandler J., Messer H., Ellender G. Cytotoxicity of gallium and indium ions compared with mercuric ion. JDent Res 1994, 73:1554-1559.
56. Han J., Burgess K. Fluorescent indicators for intracellular pH. Chem Rev 2009, 110:2709-2728.
57. Liu J., Lu W., Reigada D., Nguyen J., Laties A.M., Mitchell C.H. Restoration of lysosomal pH in RPE cells from cultured human and ABCA4-/- mice: pharmacologic approaches and functional recovery. Invest Ophthalmol Vis Sci 2008, 49:772-780.
58. von Haefen C., Wieder T., Gillissen B., Stärck L., Graupner V., Dörken B., et al. Ceramide induces mitochondrial activation and apoptosis via a bax-dependent pathway in human carcinoma cells. Oncogene 2002, 21:4009-4019.
59. Johansson A.-C., Steen H., Öllinger K., Roberg K. Cathepsin D mediates cytochrome c release and caspase activation in human fibroblast apoptosis induced by staurosporine. Cell Death Differ 2003, 10:1253-1259.